Churg-Strauss syndrome epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
(→Age) |
No edit summary |
||
| (7 intermediate revisions by the same user not shown) | |||
| Line 2: | Line 2: | ||
{{Churg-Strauss syndrome}} | {{Churg-Strauss syndrome}} | ||
{{CMG}}{{APM}}{{AE}}{{ | {{CMG}}{{APM}}{{AE}}{{CK}} | ||
==Overview== | ==Overview== | ||
The | The [[incidence]] of [[eosinophilic granulomatosis with polyangiitis]] ranges from 2.5 to 16.6 per 100,000 individuals. [[Prevalence]] ranges from 2 to 16 per 100,000 individuals. Mean age at [[diagnosis]] is usually around 45-50 years. In general, [[eosinophilic granulomatosis with polyangiitis]] affects men and women equally. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence=== | ===Prevalence=== | ||
The prevalence of | The [[prevalence]] of [[eosinophilic granulomatosis with polyangiitis]] ranges from 2 to 16 per 100,000 individuals.<ref name="pmid15073927">{{cite journal |vauthors=Martin RM, Wilton LV, Mann RD |title=Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies |journal=Pharmacoepidemiol Drug Saf |volume=8 |issue=3 |pages=179–89 |date=May 1999 |pmid=15073927 |doi=10.1002/(SICI)1099-1557(199905/06)8:3<179::AID-PDS414>3.0.CO;2-K |url=}}</ref> | ||
===Incidence=== | ===Incidence=== | ||
The incidence of | The [[incidence]] of [[eosinophilic granulomatosis with polyangiitis]] range from 2.5 to 16.6 per 100,000 individuals.<ref name="pmid11926627">{{cite journal |vauthors=Loughlin JE, Cole JA, Rothman KJ, Johnson ES |title=Prevalence of serious eosinophilia and incidence of Churg-Strauss syndrome in a cohort of asthma patients |journal=Ann. Allergy Asthma Immunol. |volume=88 |issue=3 |pages=319–25 |date=March 2002 |pmid=11926627 |doi=10.1016/S1081-1206(10)62015-7 |url=}}</ref> | ||
==Demographics== | ==Demographics== | ||
===Age=== | ===Age=== | ||
| Line 15: | Line 17: | ||
===Gender=== | ===Gender=== | ||
In general, there is no gender predilection to [[ | In general, there is no gender predilection to [[eosinophilic granulomatosis with polyangiitis]] in western nations. In Japan, female predominance has been noted.<ref name="pmid24289197">{{cite journal |vauthors=Sada KE, Amano K, Uehara R, Yamamura M, Arimura Y, Nakamura Y, Makino H |title=A nationwide survey on the epidemiology and clinical features of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) in Japan |journal=Mod Rheumatol |volume=24 |issue=4 |pages=640–4 |date=July 2014 |pmid=24289197 |doi=10.3109/14397595.2013.857582 |url=}}</ref> | ||
===Race=== | ===Race=== | ||
In general, there is no racial | In general, there is no racial predominance to [[eosinophilic granulomatosis with polyangiitis]]. | ||
==References== | ==References== | ||
Latest revision as of 13:50, 10 April 2018
|
Churg-Strauss syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Churg-Strauss syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Churg-Strauss syndrome epidemiology and demographics |
|
Churg-Strauss syndrome epidemiology and demographics in the news |
|
Blogs on Churg-Strauss syndrome epidemiology and demographics |
|
Risk calculators and risk factors for Churg-Strauss syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [3]
Overview
The incidence of eosinophilic granulomatosis with polyangiitis ranges from 2.5 to 16.6 per 100,000 individuals. Prevalence ranges from 2 to 16 per 100,000 individuals. Mean age at diagnosis is usually around 45-50 years. In general, eosinophilic granulomatosis with polyangiitis affects men and women equally.
Epidemiology and Demographics
Prevalence
The prevalence of eosinophilic granulomatosis with polyangiitis ranges from 2 to 16 per 100,000 individuals.[1]
Incidence
The incidence of eosinophilic granulomatosis with polyangiitis range from 2.5 to 16.6 per 100,000 individuals.[2]
Demographics
Age
The mean age at diagnosis of eosinophilic granulomatosis with polyangiitis is around 45-50 years.
Gender
In general, there is no gender predilection to eosinophilic granulomatosis with polyangiitis in western nations. In Japan, female predominance has been noted.[3]
Race
In general, there is no racial predominance to eosinophilic granulomatosis with polyangiitis.
References
- ↑ Martin RM, Wilton LV, Mann RD (May 1999). "Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies". Pharmacoepidemiol Drug Saf. 8 (3): 179–89. doi:10.1002/(SICI)1099-1557(199905/06)8:3<179::AID-PDS414>3.0.CO;2-K. PMID 15073927.
- ↑ Loughlin JE, Cole JA, Rothman KJ, Johnson ES (March 2002). "Prevalence of serious eosinophilia and incidence of Churg-Strauss syndrome in a cohort of asthma patients". Ann. Allergy Asthma Immunol. 88 (3): 319–25. doi:10.1016/S1081-1206(10)62015-7. PMID 11926627.
- ↑ Sada KE, Amano K, Uehara R, Yamamura M, Arimura Y, Nakamura Y, Makino H (July 2014). "A nationwide survey on the epidemiology and clinical features of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) in Japan". Mod Rheumatol. 24 (4): 640–4. doi:10.3109/14397595.2013.857582. PMID 24289197.